BioLine RX Ltd ADR buy melinda
Start price
18.11.17
/
50%
€219.19
Target price
18.05.18
€304.43
Performance (%)
-14.59%
End price
18.05.18
€187.20
Summary
This prediction ended on 18.05.18 with a price of €187.20. The prediction for BioLine RX Ltd ADR disappointed with a performance of -14.59%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
BioLine RX Ltd ADR | -2.679% | -2.679% | -67.751% | -76.304% |
iShares Core DAX® | 1.164% | 1.549% | 24.351% | 23.659% |
iShares Nasdaq 100 | 0.118% | 0.969% | 28.865% | 41.786% |
iShares Nikkei 225® | 1.124% | -1.120% | 17.443% | 6.454% |
iShares S&P 500 | 0.479% | 1.068% | 28.585% | 42.511% |
According to melinda what are the pros and cons of BioLine RX Ltd ADR for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread BioLine RX Ltd ADR diskutieren
Biotechnologie und medizinische SecteurRecherche
(Laufzeit überschritten)
Stopped prediction by melinda for BioLine RX Ltd ADR
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€2.46
03.11.20
03.11.20
€3.50
04.11.21
04.11.21
-4.88%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€148.15
03.11.18
03.11.18
€284.13
22.01.19
22.01.19
-20.14%
22.01.19
22.01.19
Could be worthwhile Investment >10% per year
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€217.16
27.01.17
27.01.17
€253.69
16.02.17
16.02.17
20.49%
16.02.17
16.02.17
Could be worthwhile Investment >10% per year
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€166.40
28.06.16
28.06.16
€192.80
24.08.16
24.08.16
21.91%
24.08.16
24.08.16
Could be worthwhile Investment >10% per year